David G. Kaiser

1.9k total citations
51 papers, 1.5k citations indexed

About

David G. Kaiser is a scholar working on Spectroscopy, Pharmacology and Analytical Chemistry. According to data from OpenAlex, David G. Kaiser has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Spectroscopy, 13 papers in Pharmacology and 12 papers in Analytical Chemistry. Recurrent topics in David G. Kaiser's work include Analytical Chemistry and Chromatography (15 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Analytical Methods in Pharmaceuticals (11 papers). David G. Kaiser is often cited by papers focused on Analytical Chemistry and Chromatography (15 papers), Pharmacogenetics and Drug Metabolism (13 papers) and Analytical Methods in Pharmaceuticals (11 papers). David G. Kaiser collaborates with scholars based in United States, Switzerland and Austria. David G. Kaiser's co-authors include Garrett J. Vangiessen, William J. Wechter, Jerome A. Dempsey, James B. Skatrud, Gordon W. Halstead, Robert Martin, Thomas A. Baillie, E. M. Glenn, Wade J. Adams and David G. Loughhead and has published in prestigious journals such as Gastroenterology, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

David G. Kaiser

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David G. Kaiser United States 24 483 414 310 244 204 51 1.5k
Thomas E. Gaffney United States 27 282 0.6× 226 0.5× 263 0.8× 235 1.0× 355 1.7× 55 1.9k
H. Hücker United States 19 189 0.4× 447 1.1× 357 1.2× 163 0.7× 371 1.8× 59 1.6k
Dennis E. Drayer United States 29 283 0.6× 309 0.7× 525 1.7× 260 1.1× 554 2.7× 64 2.5k
J. H. G. Jonkman Netherlands 29 298 0.6× 428 1.0× 571 1.8× 342 1.4× 382 1.9× 115 2.4k
Kenneth S. Albert United States 26 186 0.4× 561 1.4× 332 1.1× 189 0.8× 146 0.7× 64 1.7k
B. Norlander Sweden 23 195 0.4× 281 0.7× 153 0.5× 214 0.9× 168 0.8× 53 1.1k
Irving Sunshine United States 23 448 0.9× 178 0.4× 182 0.6× 260 1.1× 235 1.2× 111 1.8k
Robert A. Upton United States 27 188 0.4× 675 1.6× 425 1.4× 275 1.1× 339 1.7× 62 2.2k
Marcel H. Bickel Switzerland 28 235 0.5× 367 0.9× 547 1.8× 117 0.5× 699 3.4× 94 2.1k
P M Bélanger Canada 18 136 0.3× 140 0.3× 359 1.2× 76 0.3× 197 1.0× 50 888

Countries citing papers authored by David G. Kaiser

Since Specialization
Citations

This map shows the geographic impact of David G. Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Kaiser more than expected).

Fields of papers citing papers by David G. Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Kaiser. The network helps show where David G. Kaiser may publish in the future.

Co-authorship network of co-authors of David G. Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Kaiser. A scholar is included among the top collaborators of David G. Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Kaiser. David G. Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaiser, David G., et al.. (2024). Performance and Reliable Operation of Physiological Controllers Under Various Cardiovascular Models: In Silico and In Vitro Study. ASAIO Journal. 70(6). 485–494. 1 indexed citations
2.
Kaiser, David G., Martin Smieško, Stephan Kopp, Peter Chiba, & Gerhard F. Ecker. (2005). Interaction Field Based and Hologram Based QSAR Analysis of Propafenone-type Modulators of Multidrug Resistance. Medicinal Chemistry. 1(5). 431–444. 8 indexed citations
3.
Graff, Jochen, et al.. (2002). Effects of antiplatelet agents on platelet-induced thrombin generation. International Journal of Clinical Pharmacology and Therapeutics. 40(4). 135–141. 26 indexed citations
4.
Gifford, Eric, et al.. (1994). An Analysis of the Relative Occurrence ofN-Demethylation andN-Oxidation in Xenobiotic Metabolism Using Structure-Reactivity Maps. SAR and QSAR in environmental research. 2(1-2). 105–127.
5.
Shirley, Michael A., Xiangming Guan, David G. Kaiser, Gordon W. Halstead, & Thomas A. Baillie. (1994). Taurine conjugation of ibuprofen in humans and in rat liver in vitro. Relationship to metabolic chiral inversion.. Journal of Pharmacology and Experimental Therapeutics. 269(3). 1166–1175. 37 indexed citations
6.
Laizure, S. Casey, et al.. (1993). Disposition of tirilazad (U74006F), a 21-aminosteroid, in the plasma, heart, brain, and liver of the rat.. Drug Metabolism and Disposition. 21(5). 951–954. 8 indexed citations
7.
Gifford, Eric, et al.. (1992). Visualizing relative occurrences in metabolic transformations of xenobiotics using structure-activity maps. Journal of Chemical Information and Computer Sciences. 32(6). 591–599. 2 indexed citations
8.
Lesnefsky, Edward J., et al.. (1992). The Lazaroid U74006F, a 21-Aminosteroid Inhibitor of Lipid Peroxidation, Attenuates Myocardial Injury from Ischemia and Reperfusion. Journal of Cardiovascular Pharmacology. 20(2). 230–235. 29 indexed citations
9.
Porubek, David J., Mark P. Grillo, David G. Kaiser, et al.. (1991). Metabolic chiral inversion of flurbiprofen-CoA In vitro. Biochemical Pharmacology. 42(1). R1–R4. 21 indexed citations
10.
Adams, Wade J., et al.. (1991). Mechanistic studies on the metabolic chiral inversion of R-ibuprofen in the rat.. Drug Metabolism and Disposition. 19(2). 405–410. 32 indexed citations
11.
Argenta, Louis C., et al.. (1990). The Fate of Soluble Steroids Within Breast Prostheses in Humans. Annals of Plastic Surgery. 24(5). 427–430. 5 indexed citations
12.
Adams, Wade J., et al.. (1990). Studies on the metabolism and chiral inversion of ibuprofen in isolated rat hepatocytes.. Drug Metabolism and Disposition. 18(4). 527–533. 35 indexed citations
13.
Robert, André, Felix W. Leung, David G. Kaiser, & Paul H. Guth. (1989). Potentiation of Aspirin-Induced Gastric Lesions by Exposure to Cold in Rats. Gastroenterology. 97(5). 1147–1158. 11 indexed citations
14.
15.
Kaiser, David G., Robert G. Carlson, & K.T. Kirton. (1974). GLC Determination of Medroxyprogesterone Acetate in Plasma. Journal of Pharmaceutical Sciences. 63(3). 420–424. 35 indexed citations
16.
Kaiser, David G., Sophie Shaw, & Garrett J. Vangiessen. (1974). GLC Determination of dl-2-(2-Fluoro-4-Biphenylyl)Propionic Acid (Flurbiprofen) in Plasma. Journal of Pharmaceutical Sciences. 63(4). 567–570. 32 indexed citations
17.
Kaiser, David G. & Garrett J. Vangiessen. (1974). GLC Determination of Ibuprofen [(±)-2-(p-Isobutylphenyl)propionic Acid] in Plasma. Journal of Pharmaceutical Sciences. 63(2). 219–221. 68 indexed citations
18.
Wagner, John G., et al.. (1966). The effect of the dosage form on serum levels of indoxole. Clinical Pharmacology & Therapeutics. 7(5). 610–619. 36 indexed citations
19.
Kaiser, David G.. (1963). Radioisotopic Assay for Neomycins B, C, and Neamine.. Analytical Chemistry. 35(4). 552–554. 15 indexed citations
20.
Kaiser, David G.. (1962). A STUDY OF THE SLOW NEUTRON ACTIVATION ANALYSIS OF CERTAIN ARSENIC AND ANTIMONY CONTAINING PHARMACEUTICALS. Purdue e-Pubs (Purdue University System). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas E. Gaffney Breakdown of academic impact, for papers by H. Hücker Breakdown of academic impact, for papers by Dennis E. Drayer Breakdown of academic impact, for papers by J. H. G. Jonkman Breakdown of academic impact, for papers by Kenneth S. Albert Breakdown of academic impact, for papers by B. Norlander Breakdown of academic impact, for papers by Irving Sunshine Breakdown of academic impact, for papers by Robert A. Upton Breakdown of academic impact, for papers by Marcel H. Bickel Breakdown of academic impact, for papers by P M Bélanger
Rankless by CCL
2026